Table 1 Patient characteristics.
Variables | ILE | MPR | p-value |
---|---|---|---|
Male gender | 68 (81.9%) | 65 (66.3%) | 0.019 |
Age [years] | 63.0 (41–80) | 62.0 (26–82) | 0.631 |
BMI [kg/m²] | 24.2 (15.6–41.3) | 26.5 (15.9–39.0) | 0.041 |
ASA | 0.431 | ||
1 | 6 (7.2%) | 9 (9.2%) | |
2 | 40 (48.2%) | 37 (37.8%) | |
3 | 33 (39.8%) | 49 (50.0%) | |
4 | 4 (4.8%) | 3 (3.1%) | |
Chronic lung disease | 16 (19.3%) | 35 (35.7%) | 0.020 |
Chronic kidney disease | 6 (7.2%) | 10 (10.2%) | 0.602 |
Induction therapy | |||
Chemo | 42 (50.6%) | 8 (8.2%) | <0.0001 |
Radio | 20 (24.1%) | 2 (2.0%) | <0.0001 |
Indication | 0.007 | ||
Malignancy | 82 (98.8%) | 87 (88.8%) | |
Primary Tumor | 82 (100%) | 81 (93.1%) | |
Metastasis | 0 | 5 (5.7%) | |
Lymphoma | 0 | 1 (1.1%) | |
Benign disease | 1 (1.2%) | 11 (11.2%) |